Global Non-alcoholic Steatohepatitis Market 2016-2020

SKU ID : TNV- 10278907

Publishing Date : 06-May-2016

No. of pages : 70


  • About Non-Alcoholic Steatohepatitis (NASH)

    NAFL disease, also known as fatty infiltration, is characterized by the accumulation of fat in the liver. It is of two types: NAFL and NASH. Fatty inflammation characterized by higher fat deposition than the normal level, 5%-10%, causes the disease. NASH causes severe inflammation of the liver, leading to damage of the organ. It is a benign condition of unknown etiology and is asymptomatic in nature during its initial stages, resulting in late diagnosis. Conditions such as obesity, diabetes, hyperlipidemia, insulin resistance, and toxicity by drugs such as amiodarone, tamoxifen, and perhexiline maleate can cause NASH.

    Technavio’s analysts forecast the global NASH market to grow at a CAGR of 24.58% during the period 2016-2020.

    Covered in this report
    The report covers the present scenario and the growth prospects of the global NASH market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of off-label drugs, originally indicated for the treatment of diabetes, obesity, and associated conditions.

    The market is divided into the following segments based on geography:
    • Americas
    • APAC
    • EMEA

    Technavio's report, Global NASH Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key vendors
    • Arena Pharmaceuticals
    • AstraZeneca
    • F Hoffmann-La Roche
    • GSK
    • Novo Nordisk
    • Vivus

    Other prominent vendors
    • Arisaph Pharmaceuticals
    • Cempra Pharmaceuticals
    • Galectin Therapeutics
    • Galmed Pharmaceuticals
    • Genfit
    • Gilead
    • Immuron
    • Interceptpharma
    • Raptor Pharmaceutical
    • Shire
    • Tobira Therapeutics
    • Verva
    • Viking Therapeutics

    Market driver
    • Increase in sedentary lifestyle
    • For a full, detailed list, view our report

    Market challenge
    • Limited understanding of disease pathophysiology
    • For a full, detailed list, view our report

    Market trend
    • Patient assistance programs
    • For a full, detailed list, view our report

    Key questions answered in this report
    • What will the market size be in 2020 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?
    • What are the market opportunities and threats faced by the key vendors?
    • What are the strengths and weaknesses of the key vendors?

    You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

    Frequently Asked Questions

    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports